Federal health officials extended telemedicine rules that allow doctors to prescribe certain controlled medications without a prior in-person visit through the end of 2026, preventing a sudden cutoff in care for millions of patients. The U.S. Department of Health and Human Services, working jointly with the Drug Enforcement Administration, announced a fourth temporary extension of pandemic-era telehealth flexibilities, keeping them in place from January 1 through December 31, 2026.
Without the extension, patients who rely on virtual care could have abruptly lost access to medications they depend on. This includes seniors, rural residents, people with disabilities, and those receiving treatment for mental health conditions or substance use disorder. HHS Deputy Secretary Jim O’Neill said the flexibilities have become a critical part of modern health care delivery. “The flexibilities have become a critical part of modern health care delivery, allowing continuity of care while permanent, long-term policies are completed,” he said, noting the extension balances patient access with safeguards designed to prevent diversion and misuse.
Recent Impacts and Data
Telemedicine prescribing rules were first relaxed during the COVID-19 public health emergency and have been repeatedly extended as federal agencies study their impact. In 2024 alone, more than 7 million prescriptions for controlled medications were issued via telemedicine without a prior in-person visit. Federal officials point to the consequences when telehealth flexibilities lapsed in September 2025: fee-for-service telemedicine visits dropped by 24 percent, sharply limiting access for many patients almost overnight.
The extension gives HHS and the DEA additional runway to finalize permanent regulations, including a proposed Special Registration for Telemedicine. That framework is intended to establish clear national standards for prescribing controlled substances remotely while maintaining patient safety and regulatory oversight. Officials stressed that the extension does not loosen existing safeguards. Prescriptions must still be issued for legitimate medical purposes, by properly licensed practitioners, and in full compliance with federal and state law.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.mychesco.com/a/news/national/telemedicine-cliff-averted-as-feds-extend-online-prescribing-into-2026/